Haematopoiesis is the process by which the cellular con stituents of blood are continually replenished through out the lifetime of an organism. The haematopoietic system consists of various populations of highly spe cialized cells that have unique functions, such as oxygen transport and immune defence 1 . It is estimated that an adult human generates ~4-5 × 10 11 haematopoietic cells per day 2 . The continuous production of many blood cell types requires a highly regulated, yet highly responsive, system. Within the mammalian haematopoietic organi zation, rare haematopoietic stem cells (HSCs) sit at the top of the hierarchy. In adults, HSCs are found primar ily in the bone marrow (BM) and are characterized by their ability to self renew and produce various progeni tors that proliferate and differentiate into mature blood cells 3 . HSCs are essential to replenish the haematopoietic system after transplantation into recipients with ablated marrow 4,5 or after injury or infection [6] [7] [8] [9] . By contrast, committed progenitors have limited self-renewal ability, exhibit restricted lineage differentiation potential and exhaust within a few weeks after transplantation 3 . At steady state, most HSCs are quiescent, which pro tects them from genotoxic insults 10-13 , whereas the bulk of haematopoiesis is ensured by downstream progeni tors [14] [15] [16] . Several studies using single cell transplantation and in vitro differentiation have challenged the classi cal hierarchical differentiation tree of haematopoietic progenitors, instead revealing lineage restricted pro genitors (restricted to one or two lineages) that may bypass multipotent progenitors and are generated directly from HSCs [17] [18] [19] . To ensure haematopoietic homeostasis throughout life, the balance between differentiation and self renewal needs to be tightly regulated: excessive differentiation or insufficient self renewal depletes the HSC pool, whereas insufficient differentiation or unrestrained self renewal can lead to myeloproliferative diseases or leukaemia. HSC activity is regulated by an intricate inter play of cell intrinsic factors, such as transcriptional and epigenetic regulators and metabolic pathways, and cell extrinsic cues, including long range humoral and neural signals or local cues from the BM microenvironment, which is referred to as the 'stem cell niche' .
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. It is estimated that an adult human generates ~4-5 × 10 11 haematopoietic cells per day 2 . The continuous production of many blood cell types requires a highly regulated, yet highly responsive, system. Within the mammalian haematopoietic organi zation, rare haematopoietic stem cells (HSCs) sit at the top of the hierarchy. In adults, HSCs are found primar ily in the bone marrow (BM) and are characterized by their ability to self renew and produce various progeni tors that proliferate and differentiate into mature blood cells 3 . HSCs are essential to replenish the haematopoietic system after transplantation into recipients with ablated marrow 4, 5 or after injury or infection [6] [7] [8] [9] . By contrast, committed progenitors have limited self-renewal ability, exhibit restricted lineage differentiation potential and exhaust within a few weeks after transplantation 3 . At steady state, most HSCs are quiescent, which pro tects them from genotoxic insults [10] [11] [12] [13] , whereas the bulk of haematopoiesis is ensured by downstream progeni tors [14] [15] [16] . Several studies using single cell transplantation and in vitro differentiation have challenged the classi cal hierarchical differentiation tree of haematopoietic progenitors, instead revealing lineage restricted pro genitors (restricted to one or two lineages) that may bypass multipotent progenitors and are generated directly from HSCs [17] [18] [19] . To ensure haematopoietic homeostasis throughout life, the balance between differentiation and self renewal needs to be tightly regulated: excessive differentiation or insufficient self renewal depletes the HSC pool, whereas insufficient differentiation or unrestrained self renewal can lead to myeloproliferative diseases or leukaemia. HSC activity is regulated by an intricate inter play of cell intrinsic factors, such as transcriptional and epigenetic regulators and metabolic pathways, and cell extrinsic cues, including long range humoral and neural signals or local cues from the BM microenvironment, which is referred to as the 'stem cell niche' .
The concept of a niche was proposed by R. Schofield in 1978 (ref. 20 ) and refers to the regulatory unit that maintains and directs HSC self renewal and differenti ation. Building on this concept, new functional genetic tools, advancements in imaging methods and the dis covery of new markers for HSCs and niche cells have enabled a better understanding of the HSC microenvi ronment. The HSC niche is now viewed as a complex multi cellular network that provides molecular cues and physical interactions that are essential for HSC local ization, maintenance and differentiation. The field has grown rapidly in recent years; a search of PubMed using 'haematopoietic stem cell niche' as a search term retrieves >2,000 articles published since Schofield's sem inal 1978 article 20 ; >85% of these articles were published in the past 10 years. Although distinct BM niche con stituents have been identified, predominantly in mice, and include both HSC progeny and non haematopoietic cell types 21 , the exponential growth of knowledge has led to a paradoxical situation in which almost all cellu lar constituents of the BM have been proposed to con tribute to the niche, many of which act in redundant ways. The situation is further complicated by the fact that the HSC pool itself is functionally and molecularly heterogeneous 6, 19, [22] [23] [24] [25] [26] [27] [28] [29] , raising the possibility that distinct 'specialized' niches exist for distinct subpopulations of HSCs [30] [31] [32] . HSCs are the basis of BM transplantation -a curative therapy for haematological diseases involving the replacement of an individual's haematopoietic and immune systems with transplanted donor BM 33, 34 . The number of available donor HSCs are often insufficient for marrow reconstitution, necessitating the ex vivo expansion of HSCs, which remains a major challenge. As the HSC population can expand substantially in its native niche, an understanding of the mechanisms of HSC maintenance is a prerequisite for the develop ment of protocols to successfully expand HSC popula tions ex vivo for transplantation. Here, we review the progress of the past several years in the understanding of the HSC niche, emphasizing the cellular composition of the BM HSC niche and the molecular mechanisms and signals that underlie HSC-niche communication during homeostasis, ageing and malignancy. Finally, we discuss some unanswered questions in the field and their implications for regenerative medicine and the treatment of haematological and other cancers.
Bone marrow architecture
Understanding how HSCs and niche regulators interact requires knowledge of the microanatomical organiza tion and properties of adult BM ( fig. 1 ). The BM is an intricate organ that encompasses several haematopoi etic and non haematopoietic cell types that are inter connected by a vascular and innervated network within the cavities of long bones and axial bones 35 . Most cur rent knowledge of the HSC niche comes from studies of the long bones in mice ( fig. 1a) . However, whereas all bones support haematopoiesis in mice, in humans, the axial skeleton (which includes the cranium, sternum ( fig. 1b-d) , ribs, vertebrae and ilium) is the major haema topoietic site. The haematopoietic (red) marrow of human long bones is progressively replaced in adoles cence by 'fatty' yellow marrow that has negligible haema topoietic activity, except for in the proximal regions of the long bones 36 . Despite the differences in morphology, trabecular content and the ratio of endosteal marrow to central marrow of various bones (such as the femur, pelvis and sternum), the HSCs isolated from them have similar gene expression profiles and long term multilineage reconstitution abilities 37 . Analyses of the distribution patterns of purified and transplanted HSCs ex vivo revealed that they tend to home near the endosteal bone surfaces after BM ablation by irradiation 38, 39 and in recip ients whose BM was not ablated 40 . Haematopoietic stem and progenitor cells (HSPCs) also home preferentially to the trabecular rich metaphysis of femurs in non ablated mice, a process that was suggested to depend, in part, on hyaluronic acid 41 . Other imaging studies have reported that endogenous HSCs localize eccentrically towards the bone surface rather than in central medul lary regions 12, 30, [42] [43] [44] . HSCs isolated from the endosteal region show greater in vivo homing, lodgement and recon stitution potential than their central marrow counter parts 45, 46 . However, a recent study using optically cleared BM suggested that HSCs identified by α catulin and KIT (also known as SCFR) expression (TAble 1) are uniformly distributed in the marrow space 47 (box 1).
The periosteum is a highly vascularized and inner vated tissue, enabling the entry and exit of blood vessels 48 and nerve fibres to the bone and marrow cavity 49 . Of the autonomic nerves that reach the bone, the sym pathetic nerves have been shown to penetrate the BM space 50, 51 . Conversely, parasympathetic fibres may inner vate the distal femoral metaphysis 52 . In adult mouse BM, arterioles are wrapped by sympathetic nerves and perivascular stromal cells that express both the pericyte marker neural-glial antigen 2 (NG2) and the type VI intermediate filament protein nestin (NES), form ing structural networks termed the 'neuro reticular complex' (refs 30,53,54 ).
A unique, dense, vascular network enables the effi cient removal of waste products and the optimal delivery of nutrients, oxygen, hormones, neurotransmitters and growth factors to various locations in the bone and BM. Independently of the bone type, the oxygenated arterial blood connects with an extended network of sinusoids and exits through collecting veins 55 . Typical long bones, such as the femur, contain a central artery that enters the cortical bone through a nutrient canal and branches to form ascending and descending smaller arteries and thin walled arterioles that mostly run parallel to the long axis of the marrow cavity, close to the endosteum 30,56 . The connection between arterioles and the sinusoidal network preferentially occurs adjacent to endosteal and trabecular bone, mostly at the metaphysis but also in the diaphysis of the developing bone, and is mediated by type H vessels (also called 'transitional vessels'). The endothelium of type H vessels expresses both arteriolar and sinusoidal markers. The number of type H vessels declines when bones have reached their adult size and is markedly reduced in old mice [57] [58] [59] . Sinusoidal endothe lial cells represent the majority of the BM endothelium and seem to be less affected by ageing than transitional vessel endothelial cells. Sinusoidal vessels connect to the central venous sinus, which is found at the centre of the marrow cavity in cross section and runs the entire length of the diaphysis and metaphysis 31, 57, 60 . In turn, the central venous sinus empties into nutrient veins that pass through the nutrient canal along with the central artery, carrying deoxygenated blood and nutrient waste out of the marrow into the general circulation 61 . The vascula ture of the skeletal system has been extensively studied (reviewed elsewhere 55, 62 ).
Self-renewal
The capacity of a cell to divide and give rise to identical cells with equivalent developmental potential resulting either from an asymmetrical cell division that yields a daughter cell and a cell committed to differentiation or from a symmetrical cell division that yields two identical daughter cells.
Genotoxic insults
radiation or chemical agents that induce damage to the genetic material in cells.
Multipotent
The capacity of a single cell to give rise to progeny of multiple lineages.
Homing
The return of haematopoietic stem cells to the bone marrow by trans-endothelial migration.
Lodgement
The process by which, following homing, haematopoietic stem cells anchor in a specific region.
Periosteum
Tissue that covers the outer surface of the bone and consists of two layers: an outer fibrous layer that contains fibroblasts and collagen fibres and an inner cambium layer that consists of osteoblasts and skeletal stem cells with bone regeneration capacity.
Sinusoids specialized thin-walled capillaries with a wide lumen. sinusoids distribute evenly throughout the bone marrow and form a web of fenestrated vessels that facilitate trafficking of haematopoietic cells and factors in and out of the circulation.
Cortical bone
A type of bone tissue, also known as compact bone, that has a mechanical function, forming a hard shell for longbone diaphysis and accounting for the majority of total bone mass in the human skeleton.
Endosteum
inner surface of bone cavities and the outer surface of trabeculae bone spicules within the cavities covered by boneforming osteoblasts and bone-resorbing osteoclasts.
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Blood vessels are crucial for haematopoiesis. Definitive HSCs emerge from endothelial cells of the largest artery, and HSCs continue to be closely associated with blood vessels in embryonic and extra embryonic sites 63 . For the adult mouse BM, early studies suggested the existence of a vascular niche that regulates haemato poiesis 64 . However, the idea of a vascular HSC niche was supported by direct imaging of HSC distribution in their native microenvironment close to blood vessels 54, 65 . As discussed below, the niche is complex, with sev eral stromal and haematopoietic cells contributing to its activity 66 .
constituents of the Hsc niche Transgenic mouse models have been developed that ena ble the ablation of various endogenous cell types, deple tion of niche factors or tracing of cell lineages. Coupled with the use of advanced microscopy techniques (box 2), these models have led to the identification of several non haematopoietic and haematopoietic cell types and niche factors and their receptors as indispensable regula tors of HSC activity; these cell types and factors (figs 2,3) are discussed below. 67, 68 . In addition, studies in which HSC enriched cell populations were transplanted into recip ients without myeloablation suggested that HSPCs are preferentially located near the bone surface 40 . The presence of osteoblasts in the endosteal region, together with their ability to support expansion of haema topoietic progenitor cells in vitro 69 , led to the hypoth esis that osteoblasts are candidate niche cells. Later, in vivo studies using markers that broadly define HSPCs (lineage negative SCA1 + KIT + (LSK) cells) showed a cor relation between the numbers of osteoblasts and LSK cells [70] [71] [72] . Conditional ablation of osteoblasts, by ganci clovir treatment of mice expressing a truncated form of Postnatally , the bone marrow (BM) is the primary site of haematopoietic stem cell (HSC) maintenance and haematopoiesis. a | Longitudinal view of a femur illustrating the arrangement of blood vessels and nerves (marked in yellow) that accompany the arteries within the BM cavity. The periosteal layer covers the outer surface of the bone, and the endosteal layer is at the interface of bone and BM. Branching arteries (red) run parallel to the long axis of the marrow cavity , often close to the endosteum. These vessels feed into the sinusoidal network , which is distributed evenly throughout the marrow cavity and then coalesces to form the venous circulation (blue). b | Anterior view of the adult human sternum with attached ribs. Unlike the long bones, which mostly contain adipocytes in adult humans, the sternum has rich haematopoietic activity in both mice and humans, which makes it a suitable site to study haematopoiesis. The blood supply to the sternum originates from sternal or perforating branches located in the intersegmental spaces (between the ribs) from internal thoracic arteries that extend along the inside of the ribcage parallel to the sternum. c | Midsagittal section of the mouse sternum illustrating the six BM compartments (the human sternum comprises two bones, the manubrium and the body) with the representative image of a sternal segment showing the vasculature, which is labelled using intravenously injected antibodies against CD31 and CD144 (red) and stem cell antigen 1 (SCA1; green). Arterioles can be distinguished from the sinusoidal network by their SCA1 high expression. 72 . Enforced signalling through para thyroid hormone, a potent regulator of bone turnover, increases the number of osteoblastic cells and leads to HSC expansion mediated, at least in part, by the Notch ligand Jagged 1 (ref.
Regulation by non-haematopoietic cells

70
). Similarly, the conditional inacti vation of bone morphogenetic protein receptor type IA (BMPRIA) using Cre recombinase (Cre) expressed from the Mx1 promoter (Mx1-Cre) increases the number of N cadherinpositive osteoblasts, which also leads to HSC expansion 71 . This effect was thought to be the result of interactions between HSCs and osteoblasts mediated by the adhesion molecule N cadherin, although func tional evidence implicating N cadherin in this inter action is still lacking 71 . Indeed, subsequent studies using new markers that are highly specific for HSCs dispute these findings [73] [74] [75] . Two of the best studied cytokines that are known to be non cellautonomously required for HSC maintenance -CXC chemokine ligand 12 (CXCL12; also known as SDF1) [76] [77] [78] [79] and stem cell factor (SCF; also known as KIT ligand) 80, 81 -bind to CXC chemokine receptor 4 (CXCR4) and KIT on HSCs, respectively 82, 83 
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HSCs, suggesting that these osteolineage cells do not directly maintain HSCs, at least not via CXCL12 or SCF [84] [85] [86] . Osteoblasts can also produce other molecules that are implicated in the maintenance of HSCs, includ ing osteopontin (OPN), a negative regulator of HSC pool size 87, 88 , and thrombopoietin (THPO) 89, 90 and angiopoi etin 1 (ANGPT1; also known as ANG1) 12 , which bind to their receptors myeloproliferative leukaemia protein (MPL; also known as THPOR) and tyrosine kinase with immunoglobulin and EGF homology domains 2 (TIE2), respectively, and regulate HSC quiescence. However, the physiological contribution of osteoblast derived THPO and ANGPT1 in HSC regulation has been questioned 91, 92 . Hepatocytes, not local marrow niche cells, seem to be the major functional source of THPO required for HSC maintenance 92 . HSPCs, mega karyocytes and leptin receptor positive (LEPR + ) stromal cells seem to be the main sources of ANGPT1 in mouse BM 91 . This study also suggested that ANGPT1 does not directly affect HSC function but rather regulates niche regeneration after irradiation.
Although osteoblasts were the first cell population in the BM to be linked to HSC regulation, 3D imaging studies have shown that endogenous HSCs are not sig nificantly associated with osteoblasts 30, 43 . Taken together, these studies suggest that mature osteoblasts do not have a direct role in regulating HSC activity. However, osteolineage cells seem to support the maintenance of more committed haematopoietic progenitors, in par ticular, the lymphoid lineage 72, 85, 86, 93, 94 . The regulation of lineage committed progenitors by BM niches has been reviewed elsewhere 66 . Perivascular cells. The discovery that adult mouse BM HSCs and haematopoietic progenitor cells differentially express receptors of the signalling lymphocytic activa tion molecule (SLAM) family (including CD150, CD48 and CD244) has greatly facilitated imaging of highly purified HSCs in their native microenvironment. BM CD150
− lineage negative HSCs are local ized in relatively close proximity to sinusoids rather than being confined to the endosteum, suggesting the existence of a vascular niche 65 . Subsequent studies revealed that perivascular cells in human and mouse BM are highly enriched in niche factor expression and MSC activity 54, 95 . BM derived MSCs are rare haematopoiesis supporting stromal cells that have self renewal poten tial and the capacity to differentiate into bone, fat and cartilage. They wrap tightly around arterioles and more loosely around sinusoidal blood vessels. MSCs form colonyforming unitfibroblasts (CFUFs) or mesen spheres (nonadherent mesenchymal spheres) in vitro and, when transplanted, they contribute to ectopic for mation of an organized haematopoietic niche in which BM stromal cells and active haematopoiesis can be detected 96 . 97 . These studies indicate that MSPCs may organize the HSC niche.
HSCs are released into the circulation in a circa dian manner in response to adrenergic signals from
Box 1 | The localization of HSCs in the niche
The anatomical location of haematopoietic stem cells (HSCs) and their proximity to candidate niche cells are major criteria for defining bona fide niches 240 and their assessment is a major topic of debate in the field. Direct visualization of the bone marrow (Bm) is therefore essential to fully understand how HSCs are maintained and regulated in situ. However, this is a major challenge owing to a lack of exclusive markers for the identification and tracking of endogenous HSCs and niche cells, and to the calcified nature of bones. Initial studies traced the homing of exogenously labelled or GFP-marked haematopoietic stem and progenitor cells (HSPCs) transplanted into the Bm of recipient mice using classical histological or intravital microscopy-imaging techniques. These studies indicated that HSPCs have a close relationship with the endosteum [38] [39] [40] . However, the extensive manipulation required to purify HSCs, the possible effect of anaesthesia or surgical stress during transplantation and the limited depth of imaging are all major drawbacks of this approach.
The discovery of signalling lymphocytic activation molecule (SlAm) family receptors (such as CD150, CD48 and CD244) as HSPC markers, in studies using thinly sliced BM sections, revealed that CD150
− lineage-negative HSCs are distributed broadly in close proximity to endothelial cells and nestin (Nes)-GFP + perivascular cells 54, 65 . In mice expressing GFP from the haematopoietic promoter of Gata2, GFP
+ cells enriched in HSC activity localize in close proximity to the endosteum 44 . endogenous HSCs have also been shown to localize in perivascular niches that are enriched near the endosteum 43, 241, 242 . However, the use of histological sections is limited by the restricted z-depths. Additional technological improvements enabling 3D visualization of endogenous HSCs in situ uncovered a substantial association between a subset of quiescent HSCs and small arterioles, which themselves show a higher density in the endosteal region 30 . Upon activation and proliferation, this HSC subset distributes away from arterioles. Whole-mount 3D-imaging analyses revealed that a subset of quiescent HSCs is located adjacent to megakaryocytes in a niche that seems to be distinct from the arteriolar niche 156 . Although the 'non-arteriolar niche' is often referred to as the 'sinusoidal niche', it is important to emphasize that sinusoids are found throughout the BM and that most, if not all, haematopoietic cells -including HSCsare located in close proximity to sinusoids. However, HSC distribution in perivascular niches may not be random and may be influenced by specific microenvironments.
Of note, other studies using different tissue processing to improve translucence and using transgenic mice with selective expression of HSC reporters (TAble 1) suggested that HSCs are uniformly distributed in perisinusoidal niches. Studies using KIT immunostaining of optically cleared Bm from Ctnnal1-GFP reporter mice found that these GFP + HSCs are not associated with arterial vessels but are instead broadly and randomly distributed in the Bm (in a manner indistinguishable from randomly placed dots) 47 . Furthermore, there was no enrichment of quiescent HSCs in arteriolar areas. Another study found that homeobox b5 (HoXB5)-mCHeRRY + HSCs (imaged after chemical clearing) are homogeneously associated with ve-cadherin-positive endothelial cells 243 . In the future, it will be interesting to evaluate in greater detail the localization of HoXB5 + HSCs in the context of vascular compartments. Although clearing techniques enable deep imaging of the marrow, they also require tissue decalcification or marrow plug extraction and additional processing steps that may compromise the marrow architecture and the expression of surface markers 244 . By contrast, in support of the existence of multiple niche structures, other studies detected arteriolar and/or megakaryocyte niches containing quiescent HSCs with low levels of reactive oxygen species 31 , quiescent HSCs in close proximity to arteriolarassociated Schwann cells 136 and HSCs associated with transitional vessel endothelial cells connecting arterioles and sinusoids 58 .
Tie2-GFP
+ HSCs that are highly enriched for HSC activity also show a strong association with arterioles 245 , as does the CD82 + HSC subset that is enriched for long-term HSC potential 169 . Imaging of myeloid-biased HSCs using von Willebrand factor (Vwf)-GFP shows separate Bm niches for Vwf-GFP + HSCs and Vwf-GFP − HSCs, which are regulated by megakaryocyte-associated and arterioleassociated niche cells, respectively
32
. Thus, these studies using different HSC markers have reported differing results about HSC localization in the Bm; whether these discrepancies result from the use of different methodologies or reflect the existence of distinct HSC subpopulations will require further investigation.
Quiescence
The state of being inactive or dormant in the g 0 phase of the cell cycle, which is important for long-term function.
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(VCAM1).
A similar cell population can also be isolated from the BM of non transgenic mice and from human fetal BM using the surface markers platelet derived growth factor receptor α (PDGFRα) and CD51 (ref.
101
). Knock in of a GFP reporter at the Cxcl12 locus has revealed the exist ence of CXCL12abundant reticular (CAR) stromal cells, which are adipo osteogenic progenitors that are mainly distributed around sinusoids 79, 102 . CAR cells are also major producers of SCF 102 ; IL7, which is required for the maintenance of lymphoid progenitors and mature B cells 103 ; and the transcription factors forkhead box C1 (FOXC1) and early B cell factor 3 (EBF3), which are both required for CAR cell self maintenance 104, 105 . Subsequent studies in mice with a GFP knock in at the Scf locus showed GFP expression by endothelial cells and perivascular cells marked by the adipo osteogenic regulator Lepr 84, 106 . . Deletion of Scf or the pleiotrophin gene (Ptn) using Lepr-Cre results in deple tion of HSCs in the BM 84, 109, 110 . However, conditional deletion of Cxcl12 using Lepr-Cre mobilizes HSCs from the BM to the circulation and the spleen but has no effect on their abundance or localization in the marrow 85, 109 . In Nes-Cre ER transgenic mice, which express a tamoxifen inducible Cre-oestrogen receptor (ER) fusion protein, deletion of Cxcl12 or Scf does not markedly alter HSC numbers 84, 85 , although Nes-GFP + cells overlap substan tially with LEPR + cells in the BM 30, 101, 108 . As Nes-encoded transgenic reporters were generated and screened to label neural stem cells, their expression in the BM varies and depends on the transgenic strain. Accordingly, the Nes-Cre ER recombination efficiency in Nes-GFP + cells is very low and a Nes transgene does not appear to reflect closely the endogenous Nes expression, possibly owing to the incomplete Nes promoter regulatory elements in the Nes-GFP construct and the slow turnover of GFP. Use of Nes-Cre ER may be more appropriate for early development studies, because when tamoxifen is admin istered within the first 3 weeks after birth, the deletion of Cxcl12 depletes HSCs in the early postnatal BM . In contrast to Lepr-Cre, a Cxcl12 deletion using Ng2-Cre, which has high Cre mediated recombination efficiency in almost all Nes-GFP + cells and in >80% in LEPR + cells and CAR cells, leads to a severe reduction in the number of HSCs in the BM, HSC exit from quiescence and redistribution of a subset of HSCs away from arterioles 109 . The conditional deletion of Cxcl12 using paired related homeobox 1 (Prx1)-Cre also depletes HSCs from the BM, likely
Box 2 | The identification of HSC niche cells
A 'stem cell niche' refers to the local microenvironment within a tissue in which stem cells are maintained in an undifferentiated and self-renewable state and receive stimuli that determine their fate. Therefore, the location of stem cells in a tissue is not enough to define a niche, as the niche must have both anatomical and functional consequences. In the haematopoietic system, niche inputs are experimentally evaluated by determining their effects on haematopoietic stem cell (HSC) numbers, proliferation, localization, in vivo repopulating capacity and trafficking. Stem cell niches share several key characteristics (such as physical association between niche and stem cells or selective synthesis of stem cell maintenance factors) that make their in vivo identification possible using different methodologies.
Targeted cell-ablation studies. Genetic manipulation can be used to deplete candidate niche cells in vivo and evaluate the effect on HSCs and haematopoiesis. Ablation can be achieved by the expression of a suicide gene, such as thymidine kinase (TK) 72 or the diphtheria toxin receptor (DTR), under the control of the promoter of a gene specifically expressed in the target cell type. use of the DTR approach led to the identification of different perivascular constituents of the bone marrow (Bm) niche 30, 54, 102, [156] [157] [158] . Conversely, genetic manipulations can also be used to expand or activate putative niche candidates; for example, a correlation between the number of osteoblasts and haematopoietic stem and progenitor cells was demonstrated using this approach 70, 71 . However, these approaches rely on the specificity of the genetic manipulation in the candidate niche cell type. Additionally, in vivo genetic cell depletion cannot discriminate between direct niche-dependent and indirect niche-independent effects that result from the systemic depletion of the cell population. The experimental dissection of direct and indirect effects should always be an important consideration in studies manipulating candidate niche cells.
Identification of niche cells by the expression of niche factors.
An alternative approach to identify niche cells is to determine which cells synthesize HSC regulators, which include CXC-chemokine ligand 12 (CXCL12), stem cell factor (SCF), thrombopoietin (THPO), osteopontin (OPN), transforming growth factor-β (TGFβ), CXCL4, vascular cell adhesion molecule 1 (VCAM1), glycoprotein 130 (gp130), Notch ligands, fibroblast growth factor 1 (FGF1) and pleiotrophin ( fig. 2) .
Identification of niche cells by conditional deletion of niche factors. Putative niche cells
can also be functionally identified by conditionally deleting a gene encoding a known HSC niche factor (such as Cxcl12 (refs 85,86,109 ) or Scf 84, 109 ) by Cre-mediated recombination in candidate niche cells. This approach minimizes the off-target effects associated with the disruption of the Bm cellular architecture that occurs in cellablation studies. Furthermore, it enables a much more detailed evaluation of the individual contributions of candidate cells to overall niche activity. The main drawbacks of this approach are that it also relies on the availability of genetic models and that the final readout depends on the specificity of Cre expression and recombination efficiency. In addition, the niche capacity of some cells might also be overlooked owing to compensation by other cell types.
Other approaches. The physical proximity of HSCs and candidate niche structures may offer further insight into the HSC niche. Imaging techniques can reliably identify HSCs in their native microenvironment, and the distance between HSCs and the nearest putative niche can be easily measured. To determine whether potential associations are functionally relevant, the distribution of HSCs relative to candidate structures can be statistically compared with computer-generated models of random spot distribution in the marrow space 30, 47, 156, 157, 243 . The HSC niche capacity of stromal cells can also be tested using heterotopic transplantation assays. In these assays, candidate niche cells are embedded in a matrix or ossicle and transplanted into recipient mice to test their ability to generate haematopoietic niches with active haematopoiesis of host origin supported by a stroma of donor origin 54 . In addition, two populations of bone MSCs have been identified on the basis of the expression of PDGFRα and stem cell antigen1 (SCA1) (ref.
115
) or Cd73-GFP 116 , and two populations of skeletal stem cells isolated from whole bones have been identi fied on the basis of the expression of CD51 and CD200
(ref.
117
) or gremlin 1 (ref.
118
). The contributions of these populations of cells to steady state regulation of HSCs and their precise lineage relationship with the previously described MSPC populations have yet to be resolved. When dissecting the relationship between different MSPC populations identified using cell surface mark ers or genetic reporters or when comparing studies, the tissue processing technique utilized for cell isolation is an important consideration. Different enzymatic treatments or bone processing methods, such as crush ing or marrow flushing, can elicit phenotypically and functionally different cellular subsets, preventing direct comparison of studies. For example, SCA1 and grem lin 1 seem to be expressed mostly by bone associated MSPCs (for example, in the periosteum), which are not in direct contact with haematopoietic cells. Cells isolated from bone exhibit distinct gene expression profiles and greater clonogenicity, growth and differentiation capacity compared with those in the BM 96, 119, 120 . Bulkcell analy sis shows that niche activity measured by the expression of HSC niche factors correlates with MSC activity in the mouse and human fetal BM 101 . However, only a fraction of Nes-GFP + , CAR, LEPR + and Prx1-Cre cells con tain CFU F and multilineage differentiation capacity, suggesting that heterogeneity exists in the stromal cell population. However, the homogeneity of the stromal cell population can be substantially improved by the routine inclusion of CD51 as a marker in the analysis − erythroid and B lymphoid progenitors 121 . Although the hierarchical organization of bona fide stromal cell types may be as complex as the haematopoietic lineage tree, there is currently no evidence supporting this idea; the ongoing characterization of stromal cell types using single cell techniques will undoubtedly provide further insight. 
Sympathetic nervous system
(sNs). A branch of the autonomic nervous system that emerges from the thoracolumbar spinal cord and prepares the body for situations requiring alertness by releasing noradrenaline, which binds to adrenergic receptors.
Perivascular niches
specialized microenvironments located adjacent to the bone marrow vasculature that regulate the maintenance of haematopoietic stem cells and/or progenitor cells.
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Adipocytes. In humans, ageing accelerates BM adiposity, which is especially apparent in long bones where hae matopoietic sites are progressively replaced by fatty yellow marrow with reduced haematopoietic activity 36 . Adiponectin (ADIPOQ), an adipocyte secreted protein, impairs the proliferation of haematopoietic progeni tors in vitro 122 . Furthermore, adipocyte rich marrow (such as in the vertebrae of the mouse tail) contains fewer HSPCs than does adipocyte poor marrow (such as that in the thoracic vertebrae). In the A ZIP/F1 'fatless' mouse, BM engraftment by HSCs is acceler ated 123 . In addition, the BM recovers more quickly after transplantation or chemotherapy when mice are treated with a peroxisome proliferator activated receptor γ (PPARγ) antagonist, which inhibits adipogenesis 123, 124 . These results suggest that adipocytes are negative regulators of HSC function; however, alterations in MSPCs may also indirectly contribute to this result. A novel MSC population (CD45 − CD31 − SCA1 + CD24 + ) that is regulated by diet and ageing and can give rise to osteochondrogenic and adipogenic precursors, has been identified 125 . Consistent with the negative influence of adipocytes, co transplantation of adipogenic precursors in an intratibial injection model inhibits HSPC engraft ment and bone fracture healing in a manner mediated by the negative regulator dipeptidyl peptidase 4 (ref. Neural regulation. Innervation in the skeletal system has been suggested to regulate haematopoiesis in the bone and BM 49, 98, 127 . Whereas parasympathetic nerves only innervate the bone and do not fully penetrate the marrow 52, 128 , sympathetic nerves 50, 51 and sensory nerves 51, 129 innervate both the bone and BM. Sympathetic fibres release the neurotransmitter noradrenaline, which signals through adrenergic receptors. HSPC mobiliza tion out of the marrow to peripheral organs depends on an intact gradient of CXCL12. Granulocyte colony stimulating factor (G CSF) decreases the steepness of the gradient by selectively reducing CXCL12 levels in BM, leading to rapid HSPC egress from the BM 77, 130 . The SNS has a role in HSC mobilization in response to GCSF 54, 99 and probably in humans 100 . Importantly, G CSFinduced mobilization is associ ated with suppression of MSC and osteolineage cell function 98, 99, [131] [132] [133] . SNS signals are also important for haematopoi etic regeneration following genotoxic stress 134, 135 . Chemotherapy mediated and/or irradiation mediated toxicity can promote sympathetic neuropathy in the BM and excessive proliferation of MSCs and endothelial cells, which leads to a reduction in their niche support capacity. The administration of neuroprotective 135 or neuroregenerative 134 drugs rescues sympathetic nerve fibres and promotes the survival of niche cells and haema topoietic recovery after genotoxic insults, highlighting the potential benefit of using these drugs to protect haematopoietic niches from therapeutic injury.
Nonmyelinating Schwann cells, which are glial cells that express the marker glial fibrillary acidic protein (GFAP), insulate sympathetic and sensory nerves along arteries and promote HSC quiescence through activa tion of transforming growth factor β (TGFβ) and SMAD signalling 136 . Surgical sympathectomy by transection of the postganglionic sympathetic nerve results in the loss of BM GFAP + cells and HSCs by increased proliferation. However, as less invasive methods of surgical sympa thectomy do not result in reduced HSC numbers 98, 99, 134 , it is unclear how SNS nerves signal to Schwann cells and to what extent marrow denervation contributes to the effects on HSCs.
Whether nerves can directly influence HSC function remains poorly understood. Adrenergic signals can act directly on human haematopoietic progenitors that express the β2adrenergic receptor (ADRβ2), promot ing their migration and engraftment 137 . Furthermore, the BM is also innervated by sensory nerves 51, 129 ; how ever, very few studies have implicated them in haemato poiesis 138, 139 . Similarly, very little is known about the role of parasympathetic signalling in regulating HSC activity or the HSC microenvironment. However, the type 1 muscarinic receptor (CHRM1), which is one of the receptors for the parasympathetic neurotransmitter acetylcholine in the hypothalamus, has been shown to regulate G CSFinduced HSC mobilization from the BM via glucocorticoid hormone release 140 . 150 . Similarly, the conditional deletion of Angpt1 in perivascular cells and haematopoietic cells resulted in increased vascular leakiness 91 . Although hypoxia has been suggested to be an inherent feature of HSPCs that is independent of their spatial localization in the BM architecture 43 , a recent study indicated that the permeability of different vessels (arterioles versus sinusoids) to blood plasma affects the levels of reactive oxygen species (ROS) in neighbouring HSCs and consequently their localization in the marrow. HSPCs in the vicinity of the less permeable AECs con tain low levels of ROS and are thus quiescent, whereas those close to the leakier SECs have increased ROS levels, leading to their activation and augmenting their differentiation and migration 31 . It is unclear whether these differences arise from their specific meta bolic profiles. Future studies should focus on imaging more refined HSC populations, as the higher ROS toler ance of contaminating progenitors may confound the analysis. The large number of studies that investigated the metabolic requirements for HSC activity have been reviewed elsewhere 151 . Indepth analyses of the BM vasculature in mice of different ages identified distinct subtypes of blood vessels that have unique molecular identifiers 57, 59, 152 and are associated with distinct types of perivascu lar cell 31, 58, 60 . Notch signalling in BM endothelial cells promotes osteogenesis and the expansion of type H and arterial vessels and their coverage by perivascular PDGFRβ + mesenchymal cells 58, 152 , which is accompanied by increased SCF levels and HSC abundance in the BM 58 .
Endothelial cells.
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Together, these studies further emphasize the complex ity of BM niches by revealing the existence of molecular pathways that couple the behaviour of endothelial cells and perivascular mesenchymal cells.
Regulation by HSC descendants
In addition to the stromal niche components, the progeny of HSCs can also regulate HSC activity in a feedback loop.
Megakaryocytes. Emerging models of haematopoie sis propose that there is a close relationship between the megakaryocyte lineage and HSCs. Megakaryocyte lineage may even bypass differentiation from multipo tent progenitors and instead differentiate directly from HSCs 16, 18, 19, 29, [153] [154] [155] . In fact, a subpopulation of HSCs exists that is biased towards megakaryocyte poten tial and expresses platelet markers, such as CD41 and vWF 19, 29 , and megakaryocytes directly regulate HSC quiescence [156] [157] [158] [159] . Whole mount 3D imaging studies of HSC localization combined with computational randomization analyses showed that a subset of HSCs specifically associate with megakaryocytes and that megakaryocyte depletion leads to HSC proliferation 156 . Megakaryocytes might regulate HSC quie scence by sev eral mechanisms, including secretion of the chemokine CXCL4 (also known as PF4) 156 , TGFβ (the signalling of which, in HSCs, requires SHP1 (also known as PTPN6)) 157, 160 and THPO (mediated by C type lectin like receptor 2) 158, 159 . However, selective deletion of Thpo in haematopoietic cells (including megakaryocytes) using Vav1-Cre mice does not alter HSC abundance in the BM 92 . In contrast to steady state conditions, mega karyocytes promote HSC niche remodelling following a lethal dose of radiation through osteolineage cell expansion 161, 162 and the secretion of fibroblast growth factor 1 (FGF1) 157 . During emergency myelopoiesis, the production of TGFβ1 and CXCL4 by megakaryocytes surrounding clusters of granulocyte or macrophage progenitor cells may be an important mechanism to re establish HSC quiescence and limit the duration of the regenerative response 163 . Thus, these studies suggest that separate HSC niches exist that promote quiescence -megakaryocytes and arterioles with NG2 + cells and GFAP + nerves 30, 136 . . Splenic red pulp macrophages have an important role in HSC retention in the splenic niche by providing adhe sion via VCAM1 166 . In vivo depletion of macrophages using genetic models or clodronate loaded liposomes promotes the mobilization of HSPCs into the blood 164 . Furthermore, BM CD169 + macrophages promote the retention of HSCs in the BM by inducing the expres sion of CXCL12 and other HSC retention factors by Nes-GFP + MSCs 165 . Additionally, G CSF receptor sig nalling in BM monocytic cells has an important role in eliciting HSPC mobilization 133 . The crosstalk between macrophages and Nes-GFP + MSCs may be mediated by macrophage derived oncostatin M 167 . Macrophages may also directly regulate HSCs 168, 169 . A rare population of macrophages that are α smooth muscle actin posi tive, localized adjacent to HSCs in the BM, may protect HSPCs from exhaustion by limiting the production of ROS under stress 168 . A subset of macrophages express ing the duffy antigen receptor for chemokines (DARC; also known as ACKR1) regulate HSC quiescence via TGFβ-SMAD3 signalling 169 . However, whether the macrophages that directly influence HSCs and those that exert their effects indirectly via the niche are the same, is unknown.
The homeostatic clearance of aged CD62L low CXCR4 high neutrophils from the circulation also regulates the HSC niche 170 . The daily release and clearance of neutrophils is regulated in a circadian manner, altering CAR cell func tion and promoting the circadian egress of HSPCs into the circulation. Modulation of the niche is ultimately mediated by BM phagocytic macrophages (which are responsible for neutrophil clearance) through liver X receptor signalling 170 . While studying the mechanism of fever in models of mobilization, a group showed that GCSFinduced sympathetic tone stimulates the produc tion of prostaglandin E2 by neutrophils, which can target osteolineage cells to promote HSPC retention 171 . Tumour necrosis factor (TNF) produced by neutrophils improves vascular recovery following irradiation via TNF recep tors on host endothelial cells, which results in enhanced haematopoietic engraftment 172 . This study highlights a potential novel approach to improve BM transplantation by enhancing the recovery of the niche compartment. Together, these results provide a formal demonstration that macrophages and neutrophils directly and indirectly regulate HSC activity.
Regulatory T cells.
Initial studies suggested that subsets of T lymphocytes may be beneficial in allogeneic HSC (allo HSC) engraftment after BM transplantation 173, 174 . Improvements in intravital microscopy techniques enabled researchers to show that allo HSCs colocalized with FOXP3 + regulatory T (T reg ) cells in the endosteal area after transplantation 175 . T reg cells promote the survival of donor allo HSCs by secreting the immuno regulatory cytokine IL10. Moreover, transplanted donorderived HSCs can persist in non irradiated recipient mice for 30 days without immunosuppression. However, depletion of FOXP3 + T reg cells leads to rapid loss of allo HSCs, establishing that T reg cells are thus capable of endowing the HSC niche with immune privilege. BM CD150
high T reg cells seem to localize close to HSCs 
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and promote their quiescence at steady state (poten tially by the CD39catalysed production of adeno sine), thereby facilitating allo HSC engraftment 176 . The direct and indirect roles of T reg cells in the HSC niche may establish an immune privileged 'sanctuary' from immune attack not only for healthy HSPCs but also for malignant cells; thus, further investigation of these cells in cancer therapy is warranted.
the ageing niche Mammalian ageing is characterized by progressive tissue attrition, which is associated with degenerative diseases and an increased incidence of many types of cancer. In the haematopoietic system, age associated alter ations in immune responses that have been attributed to a decline in HSC function contribute to increased susceptibility to infections, autoimmunity, anaemia and myeloproliferative diseases 177 . Although the absolute number of phenotypically identified HSCs increases with age in mice, the regenerative potential of aged HSCs is reduced [178] [179] [180] [181] . However, these changes in HSC number are not observed in all mouse strains; in fact, the abun dance of functional HSCs in BALB/c mice decreases with age 182 . Furthermore, aged HSCs show myeloid biased differentiation upon transplantation 180, 181, [183] [184] [185] , enhanced mobilization into the circulation and reduced homing back to the BM 178, 186, 187 . Aged HSCs also localize to sites farther away from the endosteum in competitive short term homing assays in conditioned mice 188 and are redistributed away from arteriolar and megakaryocytic niches at steady state 189 compared with young HSCs, suggesting that altered HSC distribution is an additional hallmark of ageing.
The functional impairment of aged HSCs compared with their young counterparts when transplanted into young recipients 178, 180, 181 suggests that HSC ageing is a consequence of cell intrinsic alterations. Indeed, many cell intrinsic mechanisms involved in HSC ageing have been described, including defects in cell polar ity, altered transcriptional and epigenetic profiles and altered metabolism and DNA damage (reviewed else where 190, 191 ). However, transplanted young HSCs engraft at a lower efficiency in aged recipients than in young mice 180, 192 , indicating a role for cell extrinsic mechanisms in HSC ageing (fig. 4a) . Interestingly, a subpopulation of aged, myeloid restricted HSCs behaved as 'latent' multipotent HSCs, as they had myeloid restricted potential in primary transplantation but not in second ary transplantation 193 . This study suggests that the reju venation of HSCs and restoration of their multilineage potential are complex but attainable and highlights a possible role of the HSC microenvironment in this pro cess 194 (TAble 2) . For example, increased secretion of the proinflammatory chemokine CCchemokine ligand 5 (CCL5; also known as RANTES) may contribute to the myeloid biased differentiation of aged HSCs 192 . Ex vivo treatment of HSCs with CCL5 results in fewer T cells, and deletion of Ccl5 in mice rescues the myeloid biased differentiation. OPN expression by BM stromal cells decreases with age, and the injection of thrombin cleaved OPN attenuates the functional deficits of aged HSCs after transplantation 195 . MSCs also show skewed differentiation during ageing, which leads to decreased bone formation and increased adipogenesis 196, 197 . The accumulation of adipocytes in the BM may con tribute to haematopoietic alterations in aged mice owing to their negative effects on haematopoiesis 123, 125 and the concomitant expansion of the myeloid lineage 198, 199 . Age related bone loss in mice has also been associated with changes in the BM vasculature 58, 189, 200 . The number of transitional vessels, arterioles and osterix positive cells is substantially reduced in aged mice and can be restored by the activation of endothelial Notch sig nalling, although HSC function is not rejuvenated 58 . Furthermore, the BM vasculature exhibits increased leakiness, elevated ROS levels and decreased expression of CXCL12, SCF and Jagged 1 with age 200 . Co culture of young HSPCs with aged endothelial cells, as well as injection of endothelial cells into mice following myelo suppressive injury, demonstrated that aged endothe lial cells impair the function and increase the myeloid differentiation bias of young HSCs. Conversely, young endothelial cells can restore the repopulation capacity of aged HSCs but are unable to reverse their myeloid differentiation bias 200 .
Ageing also leads to marked remodelling of the BM vasculature, including shortening of arteriolar segments and loss of innervation of arterioles 189 . Surgical den ervation of the bone in young mice results in all the major features of HSC ageing, such as the expansion of myeloid biased HSCs that have reduced repopulating activity, the acquisition of cell polarity defects and an increased number of γH2AX foci (a marker of DNA damage) in HSCs. Denervation also induced remodel ling of the BM microenvironment that is reminiscent of that in aged mice, including shortening of arteriolar vessels and expansion of MSCs that have reduced clono genic capacity and expression of HSC niche factors, such as CXCL12 and SCF. Importantly, administration of an ADRβ3selective agonist in old mice substantially rejuvenated the in vivo function of aged HSCs by act ing on BM stromal cells 189 . Future studies to investigate the interplay between HSCintrinsic and HSCextrinsic mechanisms that regulate HSC ageing should offer thera peutic opportunities to mitigate ageingrelated decline in the haematopoietic system. the haematopoietic stem cell niche in cancer Consistent with the regulation of haematopoiesis by the niche (fig. 3) , emerging evidence suggests that niche constituents can also drive neoplasia ( fig. 4b) or can be remodelled to support malignant cells (fig. 4c ).
Niche-driven malignancies
One of the first indications that an altered BM niche may contribute to malignant transformation comes from two studies 201, 202 b | HSC niche alterations that promote cancer. Epigenetic or genetic lesions (lightning bolt) in stromal niche regulators can lead to the loss of inhibitory signals that control the growth of pre-malignant clones and ultimately promote myeloid malignancies. These lesions include alterations in the expression of recombination signal binding protein for immunoglobulin-κ J region (RBPJ) in endothelial cells; β-catenin in osteoblasts; Dicer 1, Shwachman-Bodian-Diamond syndrome protein (SBDS) and tyrosine-protein phosphatase non-receptor type 11 (PTPN11) in MSPCs; and deletion of Rarg (which encodes RARγ, retinoic acid receptor), Rb (which encodes RB protein) or Mib1 (which encodes mind bomb 1 protein) in undefined stromal cells. c | Cancer promotes niche remodelling. The majority of myeloid malignancies are caused by epigenetic and/or genetic mutations in haematopoietic stem and progenitor cells (HSPCs), which lead to bone marrow niche remodelling that supports cancer cell growth at the expense of normal haematopoiesis. Alterations produced by different malignancies can lead to a pro-inflammatory environment characterized by impaired MSPC differentiation, fibrosis, vascular remodelling, neuropathy and reduced production of HSC niche factors by stromal cells. Leukaemic stem cells (LSCs) can also upregulate the expression of CXC-chemokine receptor 4 (CXCR4), very late antigen 4 (VL A4) and CD44 to hijack the mechanisms of adhesion used by healthy HSPCs. ADRβ3, β 3 -adrenergic receptor ; AML , acute myeloid leukaemia; CCL , CC-chemokine ligand; CML , chronic myeloid leukaemia; CXCL12, CXC-chemokine ligand 12; IL-1β, interleukin-1β; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasm; NG2, neural-glial antigen 2; OPN, osteopontin; ROS, reactive oxygen species; SCF, stem cell factor ; SNS, sympathetic nervous system; T-ALL , T cell acute lymphoblastic leukaemia; TGFβ, transforming growth factor-β; THPO, thrombopoietin.
www.nature.com/nrm (MDS) that can sporadically transform to acute mye loid leukaemia (AML). However, deletion of Dicer1 in mature osteoblasts using Bglap-Cre does not result in malignancy 204 . Loss of Dicer 1 in MSPCs also leads to the reduced expression of Sbds, the gene mutated in human Shwachman-Bodian-Diamond syndrome, which is associated with BM failure and leukaemic predisposition. Sbds deletion in MSPCs stimulates p53 signalling and secretion of the inflammatory molecules S100A8 and S100A9, which impair haematopoiesis and favour leukaemogenesis by inducing genotoxic stress in HSPCs 205 . Conditional expression of a mutant protein tyrosine phosphatase non receptor type 11 (Ptpn11), a positive regulator of RAS signalling, in MSCs and osteoprogenitors can also drive MPN development and progression 206 . Additional support for the role of osteolineage cells in leukaemogenesis comes from studies of mice with osteoblast specific expression of constitutively active β catenin, which results in MDS and AML from increased Notch signalling in HSCs 207 . Interestingly, activation of the parathyroid hormone receptor in mouse osteoblasts augments myeloid/lymphoid or mixed lineage leukemia (MLL) (also known as lysine Nmethyltransferase 2A)-AF9 oncoprotein driven AML, whereas it reduces BCR-ABL chronic myelogenous leukaemia (CML)like disease, suggesting a disease specific role for osteolineage cells in leukaemogenesis 208 . Other cells of the microenviron ment may also influence malignant transformation, as genetic disruption of Notch signalling in endothelial cells alters miR155 expression, activates NF κB signalling and increases pro inflammatory cytokine production, which can trigger MPN like disease 209 . Overall, these studies provide evidence that the microenvironment can cause and/or support haematological malignancy in mice (fig. 4b) . However, it is unclear whether similar alterations in human only in the niche can cause human malignancies, although there are anecdotal reports of donor cell derived neoplasias after allogeneic stem cell transplantation from a healthy donor 210 . Whether this results from undetected malignant clones in the donor sample or from an altered microenvironment in the recipient has not been resolved.
Niche remodelling by malignancies
Just as healthy HSPCs can modulate the niche 91 , so too can leukaemic stem cells (LSCs) in order to compete for the BM niche 211 and remodel it further to create a cancer supportive environment. Leukaemic cells upregulate the expression of several molecules, including CXCR4 (refs [212] [213] [214] [215] ), VLA4 (also known as α4β1 integrin) 216 and the glycoprotein CD44 (refs 217,218 ); these molecules mediate the leukaemia cell adhesion and survival that confer chemoresistance and thus are being explored as therapeutic targets. BCR-ABL CML cells can induce the differentiation of MSCs into altered osteolineage progenitors through direct cell-cell contact and the secretion of THPO and CCL3, which may impair their capacity to support healthy HSCs and instead pro mote the growth of leukaemia cells 219 . Similar obser vations were reported for various mouse models of acute leukaemia, such as an MLL-AF9driven model of AML 220, 221 , a BCR-ABL driven model of blast crisis CML 222 and a model of T cell acute lymphoblastic leu kaemia (T ALL) 223, 224 . Furthermore, studies of primary AML samples from patients also showed that leukaemia cells suppressed BM adipogenesis in favour of AML supportive osteolineage differentiation from MSCs 225, 226 . Other HSC niche regulators, such as vascular endothe lial cells, are also altered in leukaemia. In mouse and human AML, an overall increase in the BM vasculature occurs 220, 227 ; however, a selective reduction in the num ber of endosteal blood vessels is observed by intravital microscopy 221 . In the latter study, vascular remodelling results from the accumulation of local proinflammatory and antiangiogenic cytokines produced by endosteal 58 • Increased vascular leakiness and elevated intracellular ROS levels 200 • Decreased expression of CXCL12, Jagged 1 (ref.
200
) and SCF 58, 200 Bone marrow MSPCs
• Decreased osteogenesis and increased adipogenesis 189, 196, 197 • Reduced number of osteoprogenitors 58 • 221 . Similarly, inhibition of endothelial derived nitric oxide normalizes the BM vascular leakiness observed in AML xenografts and improves the response to the chemo therapeutic agent cytarabine 228 , suggesting that vascu lar regulation by malignant cells is a key component of chemoresistance.
Emerging data suggest that nerves that are pre dominantly associated with blood vessels in tissues can regulate solid cancers [229] [230] [231] and haematological malignancies 220, 232 . In the MLL-AF9 mouse model of AML, infiltration of leukaemia cells into the BM leads to the degeneration of sympathetic nerve fibres around arterioles, which further promotes AML 220 . Consistent with this observation, treatment of these mice with the neurotoxin 6hydroxydopamine, which specifically damages catecholaminergic neurons 98, 99 , increases the number of phenotypic LSCs. Neuropathy is accompa nied by the proliferation of Nes-GFP + MSPCs that are primed for osteoblastic differentiation and a reduction in the abundance of HSCmaintaining NG2 + peri arteriolar niche cells. Blockade of the β2adrenergic receptor enhances AML infiltration in the BM, whereas a β2adrenergic agonist delays disease progression 220 . In a mouse model of MPN induced by the expression of a mutant form of Janus kinase 2 (JAK2 V617F ), the num ber of sympathetic fibres and Schwann cells is also reduced, which is triggered by the production of the pro inflammatory cytokine IL1β by mutant HSPCs 232 . In contrast to its effect in the MLL-AF9 mouse model of AML, neuropathy in this MPN model induces apop tosis of Nes-GFP + MSCs. MPN progression is attenu ated by the administration of a β3adrenergic agonist, which restores the sympathetic regulation of MSCs and indirectly reduces the number of LSCs 232 . Other stud ies of MPN myelofibrosis found that abnormal mega karyocytes secrete pro inflammatory paracrine signals, such as TGFβ 233 , whereas the aberrant differentiation of LEPR + MSPCs 234 and/or GLI1 + MSPCs 235 gives rise to excess myofibroblasts that promote BM fibrosis. Collectively, these studies indicate that, although dif ferent haematological malignancies share common onco genesis pathways, it is likely that their interaction with the BM microenvironment may be specific to the leu kaemia subtype. Solid tumours of non haematopoietic origin, such as prostate and breast cancer, can metasta size to the BM and modulate the HSC niche to support tumour growth 236 . Human metastatic prostate cancer cells can bind to niche derived CXCL12 and com pete with donor HSCs to occupy the niche 237, 238 . Thus, manipulating the neoplastic niche in combination with chemotherapy may be a beneficial therapeutic strategy, particularly in malignancies for which conventional therapies have been unsuccessful.
conclusions and future perspectives The past 10 years have seen extraordinary growth in the understanding of BM niches and the specific cellular and molecular components that regulate HSC activity. A range of genetically modified mouse strains combined with reporters and sophisticated imaging techniques associated with computational analyses have enabled the study of the dynamics of endogenous HSCs in their native environments. These studies support the idea that the niches for HSCs and their progeny consist of com plex arrangements of cellular constituents whose contri butions remain to be fully elucidated. Accumulating data have identified a major role for vascular and perivascular cells in HSC niche regulation. However, the most purified candidate niche cells (for example, CAR cells, Nes-GFP + cells or LEPR + cells) far outnumber HSCs, which sug gests that these mesenchymal derived populations require further fractionation or that establishment of a bona fide niche requires the participation of other cellu lar constituents 66 . Ongoing studies using single cell approaches should provide new insights about the heterogeneity of stromal cells in the HSC niche. Although conditional gene deletions or cellular depletions are powerful tools to investigate the factors and cellular participants that are involved in establishment and/or regulation of the HSC niche, the specificity of promoter and Cre recombinase excision activity is an important consideration for the interpretation of experiments in these models. Studies in which single factors are deleted in niche cells must be cautiously interpreted, as there may be compensatory production of the factor by other cells or long range signals from outside the BM (box 2).
The fact that 'space' must be made in the BM niche, using preparative myeloablative regimens, to enable HSCs to engraft has led to the notion that niches are sat urated at steady state. However, a recent study suggested that the BM may contain numerous unoccupied niches at steady state 239 , which raises a number of important questions, such as how vacant niches can be unlocked, whether they form reservoirs for haematopoietic emer gencies and whether leukaemia cells take advantage of these reservoirs to promote disease progression. These important questions also raise the basic, yet important, issue of how HSC numbers are regulated in the BM. As current imaging approaches to localize endogenous HSCs in fixed tissues may underestimate niche avail ability, improvements in intravital microscopy methods and genetic reporters to image HSC-niche interactions in real time may bypass this limitation.
Studies suggest that haematopoietic progenitors have a major role in the regulation of steady state haemato poiesis; therefore, further studies are needed to carefully evaluate the structure of putative niches established by haematopoietic progenitors and to identify novel factors that regulate stemness and the maintenance of specific types of progenitor. RNA sequencing and gene targeting approaches may help with the discov ery of these factors and their specific role in HSC and progenitor function, but ultimately proteomicsbased and lipidomics based methods will be necessary to investigate more thoroughly the various secreted factors that are presumably required to sustain haematopoie sis. These advances would enable the development of improved, chemically defined, culture systems and the design of ex vivo HSC expansion protocols to improve gene editing and transplantation efficiency. The devel opment of novel mouse models with a humanized www.nature.com/nrm microenvironment that is more permissive for human HSC niche studies would be beneficial, as currently it is difficult to recapitulate certain haematological malignancies in mice.
The underlying changes in the BM niches that pro mote the development of leukaemia suggest that dif ferent leukaemia subtypes can induce specific niche abnormalities and may differ in their niche dependence. Other important questions about niche involvement in malignancy include whether LSCs reside in specific niches, and if they do, whether LSCs of different classes (for example, myeloid versus lymphoid) localize in dif ferent niches, and what the role of these niches is in transformation from preleukaemia to acute leukaemia. As the incidence of haematological malignancies increases with age, understanding the mechanisms of HSC and niche ageing and their contribution to malig nant transformation may help in the design of thera peutic approaches to rejuvenate an aged haematopoietic system or prevent or treat haematological malignancies. 
